← Insights

UAE Medical Device Classification System: Class I to III

How the UAE classifies medical devices by risk, from Class I to Class III, and what each class means for manufacturers, importers and distributors.

How the UAE classifies medical devices by risk, from Class I to Class III, and what each class means for manufacturers, importers and distributors.

Reviewed by Mohamed Noureldin, Founder, Managing Partner & Senior Legal Consultant

UAE Medical Device Classification System: Class I to Class III Explained

Related Services: Explore our Medical Malpractice Disputes services for practical legal support in this area.

Introduction

The United Arab Emirates (UAE) has built a strong and increasingly sophisticated healthcare market. It attracts significant foreign investment and drives demand for advanced medical technologies.

Central to the integrity and safety of this market is the medical device classification UAE framework, a system administered by the Ministry of Health and Prevention (MOHAP). Classification is not merely an administrative formality. It is a critical part of the country's public health protection, designed to reduce the risks associated with medical devices and to ensure they are safe and effective for their intended use.

The system is designed to be both rigorous and comprehensive, scrutinising every product before it can be legally marketed and sold in the Emirates. Understanding it is essential for manufacturers, importers and distributors seeking to bring their products to the UAE, as non-compliance can result in significant financial penalties and denial of market access.

This article analyses the UAE's medical device classification system, its legal basis and the practical implications for businesses in the healthcare sector.

Legal Framework and Regulatory Overview

The legal framework governing medical devices in the UAE is a complex, multi-layered system designed to safeguard public health. At its core, it rests on a series of federal laws and ministerial decrees, all intended to set a high standard of safety and efficacy for medical products.

The primary regulatory authority is the Ministry of Health and Prevention (MOHAP), a federal body with the mandate to oversee the entire lifecycle of medical devices. Through its Registration and Drug Control Department, MOHAP exercises authority over every stage, from initial pre-market assessment and classification to post-market surveillance and enforcement action. The UAE treats this oversight as part of its national security strategy, as it directly affects the health and well-being of the population.

The recently enacted Federal Decree-Law No. 38 of 2024 is a landmark in the development of the UAE's regulatory landscape. The legislation has consolidated and streamlined the existing legal framework and has also introduced a more stringent and transparent system for governing medical products.

The law's emphasis on a risk-based, rigorous approach shows the government's commitment to addressing potential threats from substandard or unsafe medical devices. This approach is not merely reactive. It is a proactive strategy to identify and reduce risks before they become public health crises.

The law's requirement for a clear and unambiguous classification system is central to this strategy. It ensures that the level of regulatory scrutiny applied to a device is directly proportional to its potential risk to patients and users. This risk-based principle is fundamental to modern medical device regulation and reflects the UAE's commitment to aligning its framework with established international standards. For more information on our legal services in this area, please see our Healthcare Law page.

Medical Device Classification in the UAE: Key Requirements and Procedures

Classifying and registering a medical device in the UAE is a detailed procedure that demands strict adherence to MOHAP's guidelines. Classification is the first step, and it determines the entire regulatory pathway, including the required documentation, the level of scrutiny and the associated fees. The system gives the regulator a highly targeted, risk-based way to assess each product.

Manufacturers must first determine the correct classification of their device based on its intended purpose, duration of use and invasiveness. This initial self-assessment is then subject to verification by MOHAP as part of the registration application. An incorrect classification can lead to significant delays and potential rejection of the application.

The classification rules are complex and nuanced. A seemingly minor difference in intended use can result in a completely different classification and a more burdensome regulatory pathway. This is why it is critical to understand the rules in depth and to work with regulatory experts who can advise on the correct classification of a device.

Our legal team can guide you through the nuances of the classification process to support a smooth and efficient registration. For more details on our corporate and commercial law services, please visit our Corporate & Commercial Law page.

Class I Devices

Class I devices are the lowest risk category in the UAE's medical device classification system. These are typically non-invasive devices, or devices that come into contact with intact skin, with a simple design and a well-established safety profile. Common examples include elastic bandages, surgical gloves, thermometers and tongue depressors.

The regulatory requirements for Class I devices are intentionally the least stringent, reflecting their low-risk nature. This streamlined approach is designed to allow low-risk devices to enter the market efficiently, so they are available to healthcare providers and patients without unnecessary regulatory burden.

However, it is a serious mistake to assume that the process for Class I devices is a mere formality. Manufacturers must still compile and submit a comprehensive technical file, which serves as the core evidence of the device's safety and performance. It must include a detailed product description setting out the device's intended use, materials of construction and any relevant performance specifications.

The labelling must be clear, accurate and compliant with all UAE regulations. A declaration of conformity is also mandatory, in which the manufacturer attests that the device meets all applicable legal and technical standards.

While the process is more streamlined, it is by no means a simple administrative task. MOHAP still requires a thorough review of the submitted documentation to ensure that the device meets all applicable safety and performance standards. The integrity of the device and its manufacturing process is also subject to scrutiny, and any deficiencies can result in rejection of the application. This shows the strength of the system, even at the lowest risk level.

Class IIa and IIb Devices

Class II devices are divided into two subcategories, Class IIa and Class IIb, which represent a medium to high risk profile within the UAE's regulatory system. These devices are more complex than Class I devices and are often invasive or intended for prolonged use. The distinction between Class IIa and IIb is important, as it directly affects the level of regulatory scrutiny and the burden of evidence placed on the manufacturer.

Class IIa devices, such as blood glucose meters and hearing aids, are considered to pose a medium risk to patients. While they are more complex than Class I devices, they typically have a well-understood mechanism of action and a long history of safe use.

In contrast, Class IIb devices, which include life-sustaining equipment such as ventilators and infusion pumps, are considered to pose a medium-to-high risk. The potential for harm is significantly greater, and they are therefore subject to a more rigorous review process.

The regulatory requirements for both Class IIa and IIb devices are substantially more demanding than for Class I. The expectation of comprehensive, robust data is a cornerstone of the UAE's approach. Manufacturers must provide extensive clinical data to substantiate the safety and efficacy of their device, and this data must be of high quality and derived from well-designed studies.

The technical file for a Class II device is far more comprehensive than that required for Class I. It must contain detailed information on the device's design, including all materials, components and software. The manufacturing process must be described in detail, and evidence of a robust quality management system is mandatory. A thorough risk management file, compliant with ISO 14971, is also a critical part of the submission.

The review is particularly demanding for Class II devices. MOHAP's expert reviewers will subject the submitted data to intense scrutiny, and any perceived deficiencies or inconsistencies will be challenged. This rigorous assessment is designed to address any potential risks to patients and to ensure that only devices with a favourable risk-benefit profile are granted market access. For more information about our firm, please see our About Us page.

Class III Devices

Class III devices sit at the top of the risk scale in the UAE's medical device classification system. These are the most critical and technologically advanced devices, and they are subject to the most stringent level of regulatory control.

This category includes devices that are life-sustaining or life-supporting, as well as implantable devices with a high potential for serious harm or even death if they fail. Examples include pacemakers, which regulate the heartbeat; prosthetic heart valves, which replace diseased or damaged natural valves; and implantable cardioverter-defibrillators (ICDs), which can prevent sudden cardiac death. Because of their profound impact on patient health and safety, these devices require an exceptionally rigorous regulatory framework.

The regulatory requirements for Class III devices are, without exception, the most stringent in the UAE. The burden of proof placed on the manufacturer is immense, and the expectation of comprehensive and irrefutable evidence of safety and efficacy is absolute. Manufacturers must provide extensive pre-clinical and clinical data to support their submission. This data must be of the highest quality and derived from well-designed and ethically conducted clinical trials.

The technical file for a Class III device is an exceptionally detailed and lengthy document. It must give a complete and transparent account of the device's design, including all materials, components and software. The manufacturing process is subject to the highest level of scrutiny, and manufacturers must demonstrate a robust and validated quality management system.

The review process for Class III devices is intensive, with MOHAP using its full range of regulatory tools to address any potential risks to patients. The design of the device is a key focus of the review, with particular emphasis on its long-term safety, reliability and biocompatibility. The regulator's position relative to the manufacturer is strongest at this level, and only manufacturers who can present a compelling, data-driven case for their device's safety and efficacy will gain market access.

Classification Risk Level Examples Regulatory Scrutiny
Class I Low Elastic bandages, surgical gloves Low
Class IIa Medium Blood glucose meters, hearing aids Medium
Class IIb Medium-High Ventilators, infusion pumps High
Class III High Pacemakers, heart valves, defibrillators Very High

Practical Implications for Manufacturers and Investors

Navigating the UAE's medical device classification system has significant practical implications for manufacturers and investors. The rigour of the regulatory framework demands a proactive, well-planned compliance strategy, and companies that build a strong regulatory affairs function will gain a significant competitive advantage.

Where the regulator holds most of the information and control, experienced legal counsel can help by anticipating and addressing MOHAP's concerns. A thorough understanding of the classification system is not only a compliance matter; it is a business priority that can open market access and support commercial success.

For businesses looking to expand their operations in the UAE, a comprehensive legal strategy is essential. Our construction contract lawyer services page provides further insight into the legal landscape of the UAE.

Conclusion

The UAE's medical device classification system is a critical part of its public health infrastructure. The framework is designed to be both robust and rigorous, ensuring that only safe and effective medical devices are made available to the public.

The classification of a device determines its regulatory pathway, and a thorough understanding of the system is essential for any company wishing to enter the UAE market. The legal and regulatory landscape is constantly evolving, so it is important to keep up with the latest developments.

At Nour Attorneys, we have a deep understanding of the UAE's legal and regulatory framework and can provide the guidance you need in this complex environment. For more information on how we can support you, please visit our Contact Us page.

Additional Resources

Explore more of our insights on related topics:

Call Us NowChat With Our Team On WhatsApp